BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6165512)

  • 1. Different distributions of kinetically apparent molecular varieties of alpha 2-macroglobulin in health and in patients with cryptogenic fibrosing alveolitis.
    Topping RM; Craven AH; Whiting S; Rigden BG; Turner-Warwick M; Turton CW
    Clin Sci (Lond); 1981 Mar; 60(3):261-5. PubMed ID: 6165512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of alpha 2-macroglobulin on the interaction of alpha 1-proteinase inhibitor with porcine trypsin.
    Beatty K; Travis J; Bieth J
    Biochim Biophys Acta; 1982 Jun; 704(2):221-6. PubMed ID: 6179544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The identification of distinctive forms of human alpha 2-macroglobulin by using the numerical relationship between trypsin binding in alpha- and beta-modes.
    Topping RM; Craven AH
    Biochem J; 1979 Feb; 177(2):501-8. PubMed ID: 86356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Levels of alpha 1-antitrypsin and alpha 2-macroglobulin in blood serum and its antitryptic capacity].
    Protsenko VA; Veselov VF; Protsenko AV; Kiriukhin IF; Kosik OG
    Ukr Biokhim Zh (1978); 1982; 54(4):377-82. PubMed ID: 6182660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo catabolism of alpha 1-proteinase inhibitor-trypsin, antithrombin III-thrombin and alpha 2-macroglobulin-methylamine.
    Fuchs HE; Shifman MA; Pizzo SV
    Biochim Biophys Acta; 1982 May; 716(2):151-7. PubMed ID: 6178438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic properties of alpha 2-macroglobulin-proteinase complexes. Apparent discrimination between covalently and noncovalently bound trypsin by reaction with soybean trypsin inhibitor.
    Christensen U; Sottrup-Jensen L
    Biochim Biophys Acta; 1983 Sep; 747(3):263-75. PubMed ID: 6193813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of alpha1-antitrypsin and alpha-macroglobulins in the uptake of proteinase by rabbit alveolar macrophages.
    Dolovich J; Debanne MT; Bell R
    Am Rev Respir Dis; 1975 Oct; 112(4):521-5. PubMed ID: 54012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-productive activation of the proteinase binding sites of alpha 2-macroglobulin on reaction of the inhibitor with matrix-linked trypsin.
    Björk I
    Biochem Biophys Res Commun; 1984 Jan; 118(2):691-5. PubMed ID: 6200107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypsin binding activity of alpha 2-macroglobulin in cystic fibrosis and other lung diseases.
    Schidlow DV; Kueppers F
    Am Rev Respir Dis; 1980 Jan; 121(1):31-7. PubMed ID: 6153257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective changes in trypsin, alpha 1-antitrypsin, and alpha 2-macroglobulin values as a result of sodium fluoride treatment in patients with otosclerosis.
    Causse JR; Uriel J; Berges J; Bretlau P; Shambaugh GE; Causse JB
    Am J Otol; 1985 Jan; 6(1):38-42. PubMed ID: 2579564
    [No Abstract]   [Full Text] [Related]  

  • 11. Degradation of the human proteinase inhibitors alpha-1-antitrypsin and alpha-2-macroglobulin by Bacteroides gingivalis.
    Carlsson J; Herrmann BF; Höfling JF; Sundqvist GK
    Infect Immun; 1984 Feb; 43(2):644-8. PubMed ID: 6198282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rising mortality from cryptogenic fibrosing alveolitis.
    Johnston I; Britton J; Kinnear W; Logan R
    BMJ; 1990 Nov; 301(6759):1017-21. PubMed ID: 2249048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: a comparative study.
    al-Jarad N; Strickland B; Pearson MC; Rubens MB; Rudd RM
    Thorax; 1992 Aug; 47(8):645-50. PubMed ID: 1412123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo metabolism of inter-alpha-trypsin inhibitor and its proteinase complexes: evidence for proteinase transfer to alpha 2-macroglobulin and alpha 1-proteinase inhibitor.
    Pratt CW; Pizzo SV
    Arch Biochem Biophys; 1986 Aug; 248(2):587-96. PubMed ID: 2427028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of alpha 2-macroglobulin-proteinase interactions. Studies with trypsin and plasmin.
    Christensen U; Sottrup-Jensen L
    Biochemistry; 1984 Dec; 23(26):6619-26. PubMed ID: 6085009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha1-antitrypsin phenotypes in patients with cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Baoku Y; Kalsheker N; Britton J; Johnston I
    Eur Respir J; 1997 Dec; 10(12):2881-3. PubMed ID: 9493678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis alpha 2-macroglobulin protease interaction in vitro.
    Parsons M; Romeo G
    Clin Chim Acta; 1980 Jan; 100(3):215-24. PubMed ID: 6153299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Venn A; Smith C; Cooper M; Johnston I; Britton J
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):743-7. PubMed ID: 9517585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural arrangement of the proteinase binding sites in human alpha 2-macroglobulin.
    Pochon F; Bieth JG
    Ann N Y Acad Sci; 1983; 421():81-9. PubMed ID: 6202223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional modifications of alpha 2-macroglobulin by primary amines. Kinetics of inactivation of alpha 2-macroglobulin by methylamine, and formation of anomalous complexes with trypsin.
    Van Leuven F; Cassiman JJ; Van den Berghe H
    Biochem J; 1982 Jan; 201(1):119-28. PubMed ID: 6177314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.